NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JAPIC ID: JapicCTI-101110

Registered date:

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedHypertension
Date of first enrollment08/4/2010
Target sample size
Countries of recruitment
Study typeINTERVENTIONAL
Intervention(s)Intervention name : amlodipine, irbesartan Dosage And administration of the intervention : oral Control intervention name : null

Outcome(s)

Primary OutcomeEfficacy: Change in trough BP from baseline
Secondary OutcomeEfficacy: Populations of patients whose trough BPs successively reached the target level

Key inclusion & exclusion criteria

Age minimum20
Age maximum79
GenderBOTH
Include criteriaPatients with essential hypertension who meet one of the following criteria a) Patients who are taking antihypertensive drugs b) Patients who are not taking any antihypertensive drugs and whose seated systolic blood pressure (SBP) is >=160 mmHg or whose diastolic blood pressure (DBP) is >=100 mmHg
Exclude criteriaPatients with renal, hepatic or heart desease

Related Information

Contact

public contact
Name Dainippon Sumitomo Pharma Co., Ltd. Corporate Communications
Address http://www.ds-pharma.com/inquiry/index.html
Telephone
E-mail
Affiliation
scientific contact
Name Dainippon Sumitomo Pharma Co., Ltd. Corporate Communications
Address http://www.ds-pharma.com/inquiry/index.html
Telephone
E-mail
Affiliation